Successful launch of the first edition
of Truffle Exchange

On March 21st, Truffle Capital successfully launched the first edition of Truffle Exchange. The Truffle Exchange was designed as a special forum where the CEOs of highpotential, innovative listed companies funded by (and often founded by) Truffle Capital interact with investors, analysts and financial journalists.

This event featured seven companies from the life sciences, IT and energy sectors: Carmat, which is developing a totally implantable artificial heart; Deinove, which designs bacterial cell factories for producing biofuels from biomass; Neovacs, which is developing innovative drugs for severe inflammatory diseases; Keyyo, the first VoIP e-operator dedicated to the SME market; Netbooster, which offers companies comprehensive solutions for leveraging their Internet marketing; Dietswell, which offers integrated petrol drilling/well services, and OSEAD/CMT, which is developing innovative extraction technologies and is specialised in the prospection, exploration and exploitation of lead, copper, silver and uranium deposits.

"We are delighted with the success of this first edition, which attracted lots of people from the financial community and the press - a sign of their strong interest in Truffle Capital's portfolio companies. The high-level presentations were remarkable. We will definitely be organizing this great event again next year", emphasized Henri Moulard, Truffle Capital's co-founder and Chairman.

Henri Moulard
Jean-François Fourt
Dr Philippe Pouletty
Bernard-Louis Roques

* Truffle Capital is an independent European venture capital firm established in 2002, with a share capital of €1.7 million. We manage funds over €460 million, of which €240 million came from FCPIs.